Mesa Laboratories MLAB Cash Flow Statement
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| —— | $3.63M+46.6% | $2.48M-47.8% | $4.74M+167% | -$7.11M-324% | ||
| $1.27M-0.4% | $1.27M-3.4% | $1.32M-6.3% | $1.4M+3.7% | $1.35M+22.4% | ||
| $6.79M+101% | $3.38M-11.3% | $3.81M-1.8% | $3.88M+23.7% | $3.14M-3.1% | ||
| $4.13M— | —— | —— | -$3.44M-214% | $3.02M+559% | ||
| $974K— | —— | $766K-76.7% | $3.29M+294% | -$1.69M-442% | ||
| -$324K— | —— | -$1.21M-670% | $212K— | —— | ||
| $6.95M+37.5% | $5.05M+296% | -$2.58M+56.5% | -$5.93M-162% | $9.55M+150% | ||
| —— | -$1.26M+22.5% | -$1.63M-30.2% | -$1.25M-21.1% | -$1.03M+51.6% | ||
| —— | —— | -$813K-1,578% | $55K+162% | -$89K— | ||
| -$2.15M-400% | $715K+144% | -$1.61M-166% | $2.44M+17,500% | -$14K+98.4% | ||
| $4.49M+0.9% | $4.45M-2.0% | $4.53M-0.4% | $4.55M-25.9% | $6.14M+39.9% | ||
| $0— | -$0— | -$0— | -$0— | $0— | ||
| $13.96M-25.6% | $18.75M+128% | $8.22M+334% | $1.89M-85.1% | $12.67M-30.1% | ||
| $417K-43.0% | $732K-33.0% | $1.09M+8.2% | $1.01M+33.3% | $757K-6.9% | ||
| -$0— | -$0— | -$0— | -$0-100% | $62.5K0.0% | ||
| -$417K+43.0% | -$732K+33.0% | -$1.09M-8.2% | -$1.01M-0.2% | -$1.01M-23.9% | ||
| $884K0.0% | $884K+0.2% | $882K+1.0% | $873K+0.3% | $870K+0.1% | ||
| $14.69M+69.1% | $8.69M+46.3% | $5.94M-20.2% | $7.44M-58.5% | $17.94M+90.1% | ||
| -$15.76M-61.1% | -$9.79M-24.1% | -$7.88M+6.5% | -$8.43M+48.0% | -$16.19M-57.4% | ||
| $167K-47.2% | $316K— | $0-100% | $1.5M+66.8% | $900K— | ||
| -$2.05M-124% | $8.55M+1,098% | -$857K+85.8% | -$6.04M-66.2% | -$3.64M-155% | ||
| $4.49M+0.9% | $4.45M-2.0% | $4.53M-0.4% | $4.55M-25.9% | $6.14M+39.9% | ||
| $1.27M-0.4% | $1.27M-3.4% | $1.32M-6.3% | $1.4M+3.7% | $1.35M+22.4% | ||
| —— | —— | $95K-98.4% | $5.99M— | —— | ||
| -$2.15M-400% | $715K+144% | -$1.61M-166% | $2.44M+17,500% | -$14K+98.4% | ||
| —— | $3.63M+46.6% | $2.48M-47.8% | $4.74M+167% | -$7.11M-324% | ||
| —— | -$1.26M+22.5% | -$1.63M-30.2% | -$1.25M-21.1% | -$1.03M+51.6% | ||
| -$0— | -$0— | -$0— | -$0-100% | $62.5K0.0% | ||
| —— | -$214K+62.1% | -$564K+46.8% | -$1.06M— | —— | ||
| —— | —— | $97.5M— | -$0— | —— | ||
| $14.69M+69.1% | $8.69M+46.3% | $5.94M-20.2% | $7.44M-58.5% | $17.94M+90.1% | ||
| $0— | $0— | $0— | $0— | —— | ||
| $167K-47.2% | $316K— | $0-100% | $1.5M+66.8% | $900K— | ||
| —— | —— | -$813K-1,578% | $55K+162% | -$89K— | ||
| $2.39M0.0% | $2.39M0.0% | $2.39M0.0% | $2.39M— | -$0— | ||
| —— | —— | $97M+824% | $10.5M— | —— | ||
| —— | —— | —— | —— | —— | ||
| $13.55M-24.8% | $18.02M+153% | $7.13M+707% | $884K-92.6% | $11.91M-31.2% | ||
| $13.55M-24.8% | $18.02M+153% | $7.13M+707% | $884K-92.6% | $11.91M-31.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Mesa Laboratories generate?
- Mesa Laboratories (MLAB) generated $42.8M in operating cash flow over the trailing twelve months.
- What is Mesa Laboratories's free cash flow?
- After $3.3M of capital expenditures, Mesa Laboratories's free cash flow was $39.6M over the trailing twelve months, down 7.0% year over year.
- Where does Mesa Laboratories's cash flow data come from?
- Every line is extracted from Mesa Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
